Engineers Gate Manager LP Decreases Stake in Enovis Corporation $ENOV

Engineers Gate Manager LP cut its stake in shares of Enovis Corporation (NYSE:ENOV) by 57.3% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 94,681 shares of the company’s stock after selling 126,873 shares during the period. Engineers Gate Manager LP’s holdings in Enovis were worth $1,960,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. IFP Advisors Inc raised its holdings in Enovis by 5,590.5% in the second quarter. IFP Advisors Inc now owns 1,195 shares of the company’s stock valued at $25,000 after acquiring an additional 1,174 shares in the last quarter. Allworth Financial LP purchased a new stake in shares of Enovis in the 2nd quarter valued at approximately $36,000. Integrated Wealth Concepts LLC acquired a new stake in shares of Enovis in the 2nd quarter valued at $39,000. Public Employees Retirement System of Ohio acquired a new stake in shares of Enovis in the 2nd quarter valued at $48,000. Finally, Annis Gardner Whiting Capital Advisors LLC lifted its position in shares of Enovis by 468,400.0% during the 1st quarter. Annis Gardner Whiting Capital Advisors LLC now owns 4,685 shares of the company’s stock worth $107,000 after purchasing an additional 4,684 shares during the last quarter. 98.45% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, insider Oliver Engert purchased 5,140 shares of the business’s stock in a transaction on Thursday, September 3rd. The shares were bought at an average price of $19.46 per share, with a total value of $100,024.40. Following the completion of the transaction, the insider directly owned 61,238 shares in the company, valued at approximately $1,191,691.48. This represents a 9.16% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Damien Mcdonald acquired 13,035 shares of Enovis stock in a transaction on Friday, September 4th. The stock was purchased at an average price of $19.15 per share, with a total value of $249,620.25. Following the purchase, the chief executive officer owned 247,077 shares of the company’s stock, valued at $4,731,524.55. The trade was a 5.57% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased a total of 23,293 shares of company stock worth $449,599 in the last 90 days. 2.90% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research firms recently commented on ENOV. Wells Fargo & Company dropped their target price on Enovis from $39.00 to $33.00 and set an “overweight” rating on the stock in a report on Wednesday, September 2nd. Wall Street Zen raised Enovis from a “hold” rating to a “buy” rating in a research report on Saturday. Canaccord Genuity Group dropped their price objective on Enovis from $50.00 to $45.00 and set a “buy” rating on the stock in a report on Monday, August 17th. BTIG Research dropped their price objective on Enovis from $40.00 to $36.00 and set a “buy” rating on the stock in a report on Tuesday, September 1st. Finally, Weiss Ratings raised Enovis from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, July 21st. Ten equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $40.38.

Enovis Trading Down 1.6%

Shares of Enovis stock opened at $17.92 on Wednesday. The company has a current ratio of 1.98, a quick ratio of 1.00 and a debt-to-equity ratio of 0.84. The company has a fifty day simple moving average of $24.95 and a 200-day simple moving average of $24.04. The stock has a market cap of $1.03 billion, a price-to-earnings ratio of -0.93 and a beta of 1.31. Enovis Corporation has a 12-month low of $17.30 and a 12-month high of $34.28.

Enovis (NYSE:ENOV) last posted its earnings results on Thursday, August 6th. The company reported $0.90 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $0.05. Enovis had a positive return on equity of 12.03% and a negative net margin of 47.96%.The business had revenue of $582.78 million for the quarter, compared to analysts’ expectations of $581.84 million. During the same quarter in the previous year, the firm earned $0.79 earnings per share. The business’s revenue was up 3.2% compared to the same quarter last year. Enovis has set its FY 2026 guidance at 3.520-3.730 EPS. On average, equities analysts forecast that Enovis Corporation will post 3.15 EPS for the current fiscal year.

About Enovis

Enovis Corporation is a medical technology company that develops, manufactures and distributes products designed to improve patient mobility, support recovery and restore physical function. Its offerings serve orthopedic, sports medicine, rehabilitation and pain-management markets, with products used by healthcare professionals, athletes and patients.

The company’s product portfolio includes orthopedic braces and supports, surgical solutions, cold and compression therapy systems, rehabilitation equipment, physical therapy devices and recovery technologies.